We have found an APOE epsilon 4 allelic frequency of 0.289 (95% CI 0.1
95-0.383) in Spanish AD patients (n= 88; average age = 71.2 +/- 9.37)
and of 0.061 (95% CI 0.023-0.099) in age-matched controls (n = 147; av
erage age = 71.5 +/- 10.29). Remarkably no ApoE 4/4 subjects were obse
rved in any of the age-matched control groups compared to a total of 2
2 AD patients with the ApoE 4/4 phenotype. The combined odds ratio for
subjects with one or two epsilon 4 alleles in the present study is 6.
25 (95% CI 3.13-12.60), which is one of the highest so far reported. A
ltogether our results suggest a trans-European difference in the ApoE
epsilon 4 frequency but no differences in the strength of the associat
ion between APOE4 and AD.